Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.
- DOI
- 10.1021/acs.molpharmaceut.5c01650
- Published
- 2026 Aug 3
- Container
- Molecular pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.molpharmaceut.5c01650,
title = {Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.},
author = {Peet MM and Agrahari V and Singh P and Nguyen LLH and Ouattara LA and Yang ES and Herrera C and Pegu A and Pierson TC and Nguyen TD and Doncel GF},
year = {2026},
journal = {Molecular pharmaceutics},
doi = {10.1021/acs.molpharmaceut.5c01650},
url = {https://doi.org/10.1021/acs.molpharmaceut.5c01650}
}RIS
TY - JOUR TI - Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention. AU - Peet MM AU - Agrahari V AU - Singh P AU - Nguyen LLH AU - Ouattara LA AU - Yang ES AU - Herrera C AU - Pegu A AU - Pierson TC AU - Nguyen TD AU - Doncel GF PY - 2026 JO - Molecular pharmaceutics DO - 10.1021/acs.molpharmaceut.5c01650 UR - https://doi.org/10.1021/acs.molpharmaceut.5c01650 ER -
APA
MM, P., V, A., P, S., LLH, N., LA, O., ES, Y., C, H., A, P., TC, P., TD, N., & GF, D. (2026). Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01650
Source records
- pubmed · retrieved 2026-09-25T14:26:47.105Z
- europe-pmc · retrieved 2026-09-25T14:26:47.118Z